Immunotherapy in the landscape of new targeted treatments for non-small cell lung cancer.

Immunotherapy in the landscape of new targeted treatments for non-small cell lung cancer.

Item
http://www.wikidata.org/entity/Q37619114
Safety, immunogenicity and preliminary efficacy of multiple-site vaccination with an Epidermal Growth Factor (EGF) based cancer vaccine in advanced non small cell lung cancer (NSCLC) patientsPlatelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious therapeutic targets in cancers.NSCLC cells demonstrate differential mode of cell death in response to the combined treatment of radiation and a DNA-PKcs inhibitor.Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems.Therapeutic vaccination with an EGF-based vaccine in lung cancer: a step in the transition to a chronic disease.Therapeutic cancer vaccines in the treatment of non-small-cell lung cancer.Safety and efficacy study of lung cancer stem cell vaccine.Dendritic cells combining with cytokine-induced killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer.Inhibitory effect of ketoconazole on the pharmacokinetics of a multireceptor tyrosine kinase inhibitor BMS-690514 in healthy participants: assessing the mechanism of the interaction with physiologically-based pharmacokinetic simulations.[Advances in immunotherapies for non-small cell lung cancer].
P2860

Immunotherapy in the landscape of new targeted treatments for non-small cell lung cancer.

Item
http://www.wikidata.org/entity/Q37619114
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunotherapy in the landscape of new targeted treatments for non-small cell lung cancer.
@en
Immunotherapy in the landscape of new targeted treatments for non-small cell lung cancer.
@nl
type
label
Immunotherapy in the landscape of new targeted treatments for non-small cell lung cancer.
@en
Immunotherapy in the landscape of new targeted treatments for non-small cell lung cancer.
@nl
prefLabel
Immunotherapy in the landscape of new targeted treatments for non-small cell lung cancer.
@en
Immunotherapy in the landscape of new targeted treatments for non-small cell lung cancer.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Immunotherapy in the landscape of new targeted treatments for non-small cell lung cancer.
@en
P2093
P2860
P304
P31
P356
10.1016/J.MOLONC.2009.09.001
P433
P478
P577
P5875
P698
P921
P932